VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
31 hedge funds and large institutions have $11.6M invested in Vincerx Pharma, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$208K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$233K |
| 3 |
3
Morgan Stanley
New York
|
$41.9K |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$157 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LP
26
LMR Partners
London,
United Kingdom
| $11.8K | – | – | – |
|
|
HCM
27
Hollencrest Capital Management
Newport Beach,
California
| $11.8K | – | – | – |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $6.31K | -$2.18K | -92 | -26% |
|
29
UBS Group
Zurich,
Switzerland
| $3.48K | -$3.31K | -140 | -49% |
|
|
30
Wells Fargo
San Francisco,
California
| $157 | +$22 | +1 | +17% |
|
31
Fidelity Investments
Boston,
Massachusetts
| $7 | -$6 | – | – |
|
32
Qube Research & Technologies (QRT)
London,
United Kingdom
| $5 | -$4 | – | – |
|
|
CC
33
Clearline Capital
New York
| – | -$99.9K | -4,946 | Closed |
|
|
SM
34
Sabby Management
Miami Beach,
Florida
| – | -$57.9K | -2,868 | Closed |
|
|
XT
35
XTX Topco
George Town,
Cayman Islands
| – | -$17.4K | -842 | Closed |
|